MapLight Therapeutics, Inc. (MPLT) vs Oculis Holding AG (OCS)
MapLight Therapeutics, Inc. and Oculis Holding AG are both Biotechnology companies. MapLight Therapeutics, Inc. and Oculis Holding AG are of similar size ($587.7M and $579.5M). MapLight Therapeutics, Inc. has the higher net margin (0.00% vs −6,870.1%) and the lower return on invested capital (−348.4% vs 0.00%). Across the 13 metrics below, MapLight Therapeutics, Inc. leads on 8 and Oculis Holding AG on 5.
Valuation
Profitability
| Metric | MPLT | OCS | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 100.00% | 65.16% |
| Operating margin | 0.00% | (7,383.66%) | 0.00% |
| Net margin | 0.00% | (6,870.05%) | 0.00% |
| Free cash flow margin | 0.00% | (5,525.64%) | 0.00% |
| Return on equity | (297.18%) | (44.87%) | (57.72%) |
| Return on assets | (124.79%) | (37.69%) | (49.22%) |
| Return on invested capital | (348.44%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack